Bruce Jackson's Stock Ratings

Benchmark Analyst

Bruce Jackson is an analyst at Benchmark. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/11/2024

Overall Average Return

-14.5%

Smart Score

41.8%

Overall Average Return Percentile

16th

Number of Ratings

87
Buy NowGet Alert
06/11/2024GDTCBuy Now
CytoMed Therapeutics
$2.19128.31%$5 → $5ReiteratesSpeculative Buy → Speculative BuyGet Alert
06/06/2024CDIOBuy Now
Cardio Diagnostics Hldgs
$0.58241.88%$1.35 → $2MaintainsSpeculative BuyGet Alert
06/03/2024GNLXBuy Now
Genelux
$2.49904.02%$25 → $25ReiteratesSpeculative Buy → Speculative BuyGet Alert
06/03/2024UNCYBuy Now
Unicycive Therapeutics
$0.71322.54%$3 → $3ReiteratesSpeculative Buy → Speculative BuyGet Alert
05/31/2024GNLXBuy Now
Genelux
$2.49904.02%$30 → $25MaintainsSpeculative BuyGet Alert
05/31/2024UNCYBuy Now
Unicycive Therapeutics
$0.71322.54%$3 → $3ReiteratesSpeculative Buy → Speculative BuyGet Alert
05/29/2024KNWBuy Now
Know Labs
$0.8025%$1 → $1ReiteratesSpeculative Buy → Speculative BuyGet Alert
05/28/2024RVPHBuy Now
Reviva Pharmaceuticals
$1.491040.94%$17 → $17ReiteratesSpeculative Buy → Speculative BuyGet Alert
05/24/2024HUMABuy Now
Humacyte
$7.05112.77% → $15ReiteratesBuy → BuyGet Alert
05/23/2024CLNNBuy Now
Clene
$0.391171.29% → $5ReiteratesBuy → BuyGet Alert
05/16/2024BLTEBuy Now
Belite Bio
$38.0050% → $57ReiteratesBuy → BuyGet Alert
05/14/2024BIOLBuy Now
Biolase
$0.15165.6% → $0.4ReiteratesSpeculative Buy → Speculative BuyGet Alert
05/13/2024HUMABuy Now
Humacyte
$7.05112.77% → $15ReiteratesBuy → BuyGet Alert
05/01/2024NEOBuy Now
NeoGenomics
$13.1636.78% → $18ReiteratesBuy → BuyGet Alert
04/19/2024CDIOBuy Now
Cardio Diagnostics Hldgs
$0.58130.77%$4 → $1.35MaintainsSpeculative BuyGet Alert
04/16/2024RVPHBuy Now
Reviva Pharmaceuticals
$1.491040.94% → $17ReiteratesSpeculative Buy → Speculative BuyGet Alert
04/15/2024TNONBuy Now
Tenon Medical
$0.66355.86%$5 → $3MaintainsSpeculative BuyGet Alert
04/15/2024OCXBuy Now
OncoCyte
$2.6588.68% → $5ReiteratesSpeculative Buy → Speculative BuyGet Alert
04/15/2024UNCYBuy Now
Unicycive Therapeutics
$0.71322.54% → $3ReiteratesSpeculative Buy → Speculative BuyGet Alert
04/08/2024KNWBuy Now
Know Labs
$0.8025% → $1Initiates → Speculative BuyGet Alert
04/03/2024GNLXBuy Now
Genelux
$2.491104.82% → $30ReiteratesSpeculative Buy → Speculative BuyGet Alert
03/25/2024HUMABuy Now
Humacyte
$7.05112.77% → $15ReiteratesBuy → BuyGet Alert
03/22/2024BIOLBuy Now
Biolase
$0.15165.6%$2.5 → $0.4MaintainsSpeculative BuyGet Alert
03/21/2024MODDBuy Now
Modular Medical
$1.58216.46% → $5ReiteratesSpeculative Buy → Speculative BuyGet Alert
03/20/2024CLNNBuy Now
Clene
$0.391171.29% → $5ReiteratesBuy → BuyGet Alert
01/02/2024EXASBuy Now
Exact Sciences
$42.05116.41% → $91UpgradeHold → BuyGet Alert
12/27/2023HUMABuy Now
Humacyte
$7.05112.77%$16 → $15MaintainsBuyGet Alert
12/04/2023UNCYBuy Now
Unicycive Therapeutics
$0.71322.54% → $3ReiteratesSpeculative Buy → Speculative BuyGet Alert
12/04/2023GDTCBuy Now
CytoMed Therapeutics
$2.19128.31% → $5ReiteratesSpeculative Buy → Speculative BuyGet Alert
11/24/2023GNLXBuy Now
Genelux
$2.491104.82%$38 → $30MaintainsSpeculative BuyGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free